Data management, study design, and the groundwork needed to build pharma’s digital revolution. As the pharmaceutical industry ...

Bristol Myers Squibb has agreed to acquire Orbital Therapeutics, a privately held biotechnology company pioneering a new ...

AstraZeneca has also reached an agreement with the U.S. Department of Commerce to delay Section 232 tariffs for three years, ...

Chem’s Rishi Pimentel on pharma-grade solvents, regulatory-ready excipients, and the power behind Procipient®.

Kincell will provide GMP manufacturing services to support the scale-up and clinical supply of Moonlight’s lead T cell ...

Project Execution System aims to provide seamless deliveries amidst growing pipeline and increased client demand.

ROVI’s CDMO business unit will rebrand as ROIS and acquire a sterile injectable drug product manufacturing facility from ...

Expedition Therapeutics has closed a $165 million Series A financing round to support development of its lead candidate, EXPD ...

Aims to design a vaccine capable of inducing an immune response with bactericidal activity against Pseudomonas aeruginosa.

Mission Bio, a precision medicine company, has appointed Zivjena Vucetic, M.D., Ph.D., as Chief Medical Officer.

How Piramal Pharma is shaping resilient, patient-centric development across OSDs, HPAPIs, and sterile injectables.

Anticipating trends, addressing challenges, and providing solutions that enable CDMOs to adapt to market changes.